PMS2L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.526800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.824200E-01
Normal-vs-Stage2
4.705000E-01
Normal-vs-Stage3
3.482400E-01
Normal-vs-Stage4
9.529000E-01
Stage1-vs-Stage2
7.595000E-01
Stage1-vs-Stage3
1.555410E-01
Stage1-vs-Stage4
4.550000E-01
Stage2-vs-Stage3
3.090800E-01
Stage2-vs-Stage4
3.384600E-01
Stage3-vs-Stage4
1.589570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.834200E-01
Normal-vs-AfricanAmerican
6.465800E-01
Normal-vs-Asian
4.183200E-01
Caucasian-vs-AfricanAmerican
9.574800E-01
Caucasian-vs-Asian
7.044200E-01
AfricanAmerican-vs-Asian
8.379800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.880600E-01
Normal-vs-Female
5.707200E-01
Male-vs-Female
8.394600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.574200E-01
Normal-vs-Age(41-60Yrs)
8.131200E-01
Normal-vs-Age(61-80Yrs)
6.055600E-01
Normal-vs-Age(81-100Yrs)
6.577000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.473800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.922350E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.974210E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.538400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.650810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.832400E-01
Normal-vs-Daily Drinker
4.675000E-01
Normal-vs-Weekly Drinker
7.530400E-01
Normal-vs-Occasional Drinker
9.581200E-01
Normal-vs-Social Drinker
7.535400E-01
Non Drinker-vs-Daily Drinker
7.543600E-01
Non Drinker-vs-Weekly Drinker
6.355600E-01
Non Drinker-vs-Occasional Drinker
3.771200E-01
Non Drinker-vs-Social Drinker
5.504400E-01
Daily Drinker-vs-Weekly Drinker
7.974400E-01
Daily Drinker-vs-Occasional Drinker
4.671800E-01
Daily Drinker-vs-Social Drinker
7.781000E-01
Weekly Drinker-vs-Occasional Drinker
5.620600E-01
Weekly Drinker-vs-Social Drinker
9.921800E-01
Occasional Drinker-vs-Social Drinker
5.580400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.107000E-01
Normal-vs-Grade 2
4.627900E-02
Normal-vs-Grade 3
2.811200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.744800E-01
Grade 1-vs-Grade 3
7.154000E-02
Grade 1-vs-Grade 4
3.107000E-01
Grade 2-vs-Grade 3
1.847030E-01
Grade 2-vs-Grade 4
4.627900E-02
Grade 3-vs-Grade 4
2.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.147000E-01
Normal-vs-NonDiabetic
5.617200E-01
Diabetic-vs-NonDiabetic
2.160800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.571400E-01
Normal-vs-NoPancreatitis
4.913400E-01
Pancreatitis-vs-NoPancreatitis
2.349600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.411000E-01
Normal-vs-N1
4.684800E-01
N0-vs-N1
4.812600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.330400E-01
Normal-vs-TP53-NonMutant
6.803400E-01
TP53-Mutant-vs-TP53-NonMutant
4.868300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
